Literature DB >> 27553376

Real-Life Use of Isavuconazole in Patients Intolerant to Other Azoles.

Eloy E Ordaya1, George J Alangaden1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27553376     DOI： 10.1093/cid/ciw585

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

Review 1.  Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.

Authors:  Alice J Hsu; Pranita D Tamma; Brian T Fisher
Journal:  Antimicrob Agents Chemother       Date:  2022-06-29       Impact factor: 5.938

Review 2.  Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.

Authors:  Matthew W McCarthy; Brad Moriyama; Ruta Petraitiene; Thomas J Walsh; Vidmantas Petraitis
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

3.  Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.

Authors:  Sebastian Wurster; Russell E Lewis; Nathaniel D Albert; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

4.  Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.

Authors:  Caitlin R Rausch; Adam J DiPippo; Prithviraj Bose; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

5.  Pharmacokinetics and Dialytic Clearance of Isavuconazole During In Vitro and In Vivo Continuous Renal Replacement Therapy.

Authors:  M Biagi; D Butler; X Tan; S Qasmieh; K Tejani; S Patel; R M Rivosecchi; M H Nguyen; C J Clancy; R K Shields; E Wenzler
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

Review 6.  Isavuconazole and Liposomal Amphotericin B as Successful Combination Therapy of Refractory Invasive Candidiasis in a Liver Transplant Recipient: A Case Report and Literature Review.

Authors:  Georgios Odysseos; Ulrich Mayr; Gabor Bozsaki; Christian Seidensticker; Ursula Ehmer; Roland M Schmid; Tobias Lahmer; Veronika Dill
Journal:  Mycopathologia       Date:  2021-10-31       Impact factor: 2.574

7.  Isavuconazonium for the treatment of Purpureocillium lilacinum infection in a patient with pyoderma gangrenosum.

Authors:  Julia Accetta; Emily Powell; Erin Boh; Lisa Bull; Abida Kadi; Alfred Luk
Journal:  Med Mycol Case Rep       Date:  2020-05-30

8.  Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study.

Authors:  Chiara Cattaneo; Alessandro Busca; Doriana Gramegna; Francesca Farina; Anna Candoni; Monica Piedimonte; Nicola Fracchiolla; Chiara Pagani; Maria Ilaria Del Principe; Maria Chiara Tisi; Massimo Offidani; Rosa Fanci; Stelvio Ballanti; Angelica Spolzino; Marianna Criscuolo; Francesco Marchesi; Gianpaolo Nadali; Mario Delia; Marco Picardi; Margherita Sciumé; Valentina Mancini; Attilio Olivieri; Mario Tumbarello; Giuseppe Rossi; Livio Pagano
Journal:  Hemasphere       Date:  2019-11-04

9.  Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant.

Authors:  Hiba Dagher; Ray Hachem; Anne-Marie Chaftari; Ying Jiang; Shahnoor Ali; Rita Deeba; Shivan Shah; Issam Raad
Journal:  J Fungi (Basel)       Date:  2022-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.